[go: up one dir, main page]

AU2002368044A1 - Co-stimulatory molecules - Google Patents

Co-stimulatory molecules

Info

Publication number
AU2002368044A1
AU2002368044A1 AU2002368044A AU2002368044A AU2002368044A1 AU 2002368044 A1 AU2002368044 A1 AU 2002368044A1 AU 2002368044 A AU2002368044 A AU 2002368044A AU 2002368044 A AU2002368044 A AU 2002368044A AU 2002368044 A1 AU2002368044 A1 AU 2002368044A1
Authority
AU
Australia
Prior art keywords
stimulatory molecules
stimulatory
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368044A
Other versions
AU2002368044A8 (en
Inventor
Doris Apt
Jean Chia-Chun Chang
Claes Gustafsson
Alexandra L. L. Lazetic
Steven R. Leong
Juha Punnonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen Inc
Original Assignee
Maxygen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/888,324 external-priority patent/US7094875B2/en
Priority claimed from US10/032,214 external-priority patent/US7183376B2/en
Application filed by Maxygen Inc filed Critical Maxygen Inc
Publication of AU2002368044A1 publication Critical patent/AU2002368044A1/en
Publication of AU2002368044A8 publication Critical patent/AU2002368044A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70532B7 molecules, e.g. CD80, CD86
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002368044A 2001-06-22 2002-06-21 Co-stimulatory molecules Abandoned AU2002368044A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/888,324 2001-06-22
US09/888,324 US7094875B2 (en) 2000-06-23 2001-06-22 Co-stimulatory polypeptides
AUPCT/US2001/019973 2001-06-22
PCT/US2001/019973 WO2002000717A2 (en) 2000-06-23 2001-06-22 Novel co-stimulatory molecules
US10/032,214 US7183376B2 (en) 2000-06-23 2001-12-20 Variant B7 co-stimulatory molecules
US10/032,214 2001-12-20
PCT/US2002/019898 WO2004029197A2 (en) 2001-06-22 2002-06-21 Co-stimulatory molecules

Publications (2)

Publication Number Publication Date
AU2002368044A1 true AU2002368044A1 (en) 2004-04-19
AU2002368044A8 AU2002368044A8 (en) 2004-04-19

Family

ID=56290305

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368044A Abandoned AU2002368044A1 (en) 2001-06-22 2002-06-21 Co-stimulatory molecules

Country Status (3)

Country Link
EP (1) EP1497426A2 (en)
AU (1) AU2002368044A1 (en)
WO (1) WO2004029197A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3640375A3 (en) 2012-12-11 2020-07-29 Albert Einstein College of Medicine Methods for high throughput receptor/ligand identification
EP3283508B1 (en) 2015-04-17 2021-03-17 Alpine Immune Sciences, Inc. Immunomodulatory proteins with tunable affinities
MX2018005517A (en) 2015-11-02 2018-11-09 Five Prime Therapeutics Inc Cd80 extracellular domain polypeptides and their use in cancer treatment.
KR20190006495A (en) * 2016-04-15 2019-01-18 알파인 이뮨 사이언시즈, 인코포레이티드 CD80 variant immunoregulatory proteins and uses thereof
WO2017201131A1 (en) 2016-05-18 2017-11-23 Albert Einstein College Of Medicine, Inc. Variant pd-l1 polypeptides, t-cell modulatory multimeric polypeptides, and methods of use thereof
BR112018073606A2 (en) * 2016-05-18 2019-02-26 Cue Biopharma, Inc. T-cell modulating multimeric polypeptides and methods of using them
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
WO2018119114A1 (en) 2016-12-22 2018-06-28 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
US11851471B2 (en) 2017-01-09 2023-12-26 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
EP3596118B1 (en) 2017-03-15 2024-08-21 Cue Biopharma, Inc. Combination of multimeric fusion polypeptides and immune checkpoint inhibitor for treating hpv-associated cancer
EP3596115A1 (en) 2017-03-16 2020-01-22 Alpine Immune Sciences, Inc. Pd-l2 variant immunomodulatory proteins and uses thereof
WO2018170026A2 (en) * 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
EP3628070B1 (en) 2017-04-28 2021-09-08 Five Prime Therapeutics, Inc. Cd80 extracellular domain polypeptides for use in increasing central memory t cells
SG11202003078VA (en) 2017-10-18 2020-05-28 Alpine Immune Sciences Inc Variant icos ligand immunomodulatory proteins and related compositions and methods
BR112020013236A2 (en) 2018-01-03 2020-12-01 Alpine Immune Sciences, Inc. immunomodulatory proteins from multiple domains and methods of their use
EP3737689A4 (en) 2018-01-09 2021-12-01 Cue Biopharma, Inc. MULTIMER POLYPEPTIDES T-LYMPHOCYTE MODULATORS AND THEIR METHODS OF USE
WO2019241758A1 (en) 2018-06-15 2019-12-19 Alpine Immune Sciences, Inc. Pd-1 variant immunomodulatory proteins and uses thereof
EA202190181A1 (en) * 2018-07-04 2021-05-27 Сайтоиммьюн Терапьютикс, Инк. COMPOSITIONS AND METHODS FOR TARGETED IMMUNOTHERAPY FLT3, PD-1 AND / OR PD-L1
WO2020061376A2 (en) * 2018-09-19 2020-03-26 Alpine Immune Sciences, Inc. Methods and uses of variant cd80 fusion proteins and related constructs
WO2020219896A1 (en) 2019-04-26 2020-10-29 Beijing Xuanyi Pharmasciences Co., Ltd. Cd80 variant proteins and uses thereof
AU2021272895A1 (en) 2020-05-12 2022-09-22 Cue Biopharma, Inc. Multimeric T-cell modulatory polypeptides and methods of use thereof
EP4211149A4 (en) 2020-09-09 2024-10-09 Cue Biopharma, Inc. MHC CLASS II T-CELL MODULATING MULTIMER POLYPEPTIDES FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429303B1 (en) * 1999-09-03 2002-08-06 Curagen Corporation Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
EP1360290A2 (en) * 2000-06-23 2003-11-12 Maxygen, Inc. Co-stimulatory molecules

Also Published As

Publication number Publication date
WO2004029197A2 (en) 2004-04-08
WO2004029197A8 (en) 2005-07-21
EP1497426A2 (en) 2005-01-19
WO2004029197A3 (en) 2004-10-28
AU2002368044A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU2002368044A1 (en) Co-stimulatory molecules
AU2002313565A1 (en) Putter-heads
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AU2002359320A1 (en) Novel anit-infectives
AU2002319532A1 (en) Feeding-bottles
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AU2002313073A1 (en) Phytocystatin
AU2002257925A1 (en) Numberplates
AU2001100214A4 (en) Dolly-trolley
AU2001100522A4 (en) e-Trans
AU2001100532A4 (en) FonePark
AU2001100338A4 (en) Sunglove
AU2002100746A4 (en) Adrail
AU2002316594A1 (en) Minimizing spatial-dispersion-induced birefringence
AUPR754901A0 (en) Masta technologies
AU2002254979A1 (en) Novel sulfonylamino-pyrimidines
AU2002253663A1 (en) Novel maxizyme
AU2002355888A1 (en) Novel combination
AU2002249693A1 (en) Starseparator
AU2002307690A1 (en) Cookpot
AU2002235675A1 (en) Regakine-1
AU2002253687A1 (en) Floss-pick

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase